Obtainment and study of properties of hybridomas producing anti-IL6 monocional antibody / Obtenção e estudo das propriedades de hibridomas produtores de anticorpos monoclonais anti-IL6 humana
AUTOR(ES)
Loren Semionatto Scuro
DATA DE PUBLICAÇÃO
2005
RESUMO
In the present study we have developed monoclonal antibodies against human recombinant (hr) IL6, for the use in ELISA assays to detect the human native IL6 present in biological fluid of patients or in supernatant of activated human and rodent monocytes. Two families of hibridomas (1A6 and 3B1) secreting MAb against-IL6 were obtained from the fusion of mieloma cells from SP2 Ag14/0 lineage with spleen cells from BALB/c mice, previously immunized with human recombinant IL6. Those hibridomas were selected on the basis of their reactivity with the hrIL6, through an ELISA indirect assay. The monoclonal immunoglobulins (Igs) produced by these hibridomas are from IgG1 Kappa isotype and were purified from ascitic fluid and culture supernatant by affinity chromatography. The purified proteins from the ascitic fluid were conjugated with biotin for the use in ELISA hrIL6 capture assay, to identify one or more pairs of antibodies appropriated to this kind of test, as well to define the sensibility of cytokine detection. The pair of MAbs 3B1E4 x 1A6F10-biotinilates was shown promising in ELISA assays, detecting the recombinant cytokine between 8 and 512 ng/mL, liberating elevated optical densities. All of the a-IL6 MAbs studied were capable to neutralize the biological activity of the cytokine in attempt employing the hibridoma B13.9 IL-6 dependent. Finally, the pair of hibridomas a-IL6 3B1E4 and 1A6F10 was studied as regards his main cultivation characteristics: growth, MAb production in vitro, lactate and ammonia production and glucose consumption. The N-Terminal portion sequence of 3B1E4 and 1A6F10 revealed that both light-chains present identical amino acid sequence. However, the analysis of the ten amino acid residues present in variable region of heavy-chains resulted in completely distinct sequences in both antibodies, being a strong indication of difference in their ability to recognize the antigen
ASSUNTO(S)
immunoenzyme techniques anticorpos monoclonais anticorpos bloqueadores monoclonal antibodies hibridomas hybridomas tecnicas imunoenzimaticas blocking antibodies
ACESSO AO ARTIGO
http://libdigi.unicamp.br/document/?code=vtls000374889Documentos Relacionados
- Produção de hibridomas e clones produtores de anticorpos monoclonais anti- Nucleosídeo trifosfato difosfohidrolase 1 (NTPDase-1) recombinante de Trypanosoma cruzi
- Obtainment of hybridomas for production of monoclonal antibodies against the E-NTPDase-2 of Leishmaniasis major protein
- Produção de hibridomas e clones para obtenção de anticorpos monoclonais anti-Neospora caninum Nc-1 (Apicomplexa, Sarcocystidae)
- Obtenção e estudo de anticorpos monoclonais anti Trypanosoma Cruzi Chagas, 1909
- Endogenous interleukin 6 production in multiple myeloma patients treated with chimeric monoclonal anti-IL6 antibodies indicates the existence of a positive feed-back loop.